0.4658
price up icon18.00%   0.0758
 
loading
Precedente Chiudi:
$0.39
Aprire:
$0.39
Volume 24 ore:
8.21M
Relative Volume:
3.47
Capitalizzazione di mercato:
$41.77M
Reddito:
$1.22M
Utile/perdita netta:
$-14.15M
Rapporto P/E:
-1.7915
EPS:
-0.26
Flusso di cassa netto:
$-6.55M
1 W Prestazione:
+28.19%
1M Prestazione:
+25.67%
6M Prestazione:
+63.13%
1 anno Prestazione:
+30.00%
Intervallo 1D:
Value
$0.3883
$0.4985
Intervallo di 1 settimana:
Value
$0.3481
$0.4985
Portata 52W:
Value
$0.2525
$0.4985

IGC Pharma Inc Stock (IGC) Company Profile

Name
Nome
IGC Pharma Inc
Name
Telefono
301-983-0998
Name
Indirizzo
4336 Montgomery Avenue, Bethesda, MD
Name
Dipendente
16
Name
Cinguettio
@IGCIR
Name
Prossima data di guadagno
2025-08-19
Name
Ultimi documenti SEC
Name
IGC's Discussions on Twitter

Confronta IGC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IGC
IGC Pharma Inc
0.46 33.95M 1.22M -14.15M -6.55M -0.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
389.33 99.72B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
586.50 60.67B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
451.93 58.15B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
704.58 41.45B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
300.07 36.69B 3.81B -644.79M -669.77M -6.24

IGC Pharma Inc Borsa (IGC) Ultime notizie

pulisher
09:04 AM

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q1 results. We believe more positive clinical data and progress in 2025 to be strong catalysts for stock. Raising P/T to $4.50." - ACCESS Newswire

09:04 AM
pulisher
09:00 AM

Analyst Sees Strong Catalysts for IGC Pharma in 2025, Raises Price Target Following Q1 Results - Stock Titan

09:00 AM
pulisher
Aug 26, 2025

Leading vs lagging indicators on IGC Pharma Inc. performanceJuly 2025 Market Mood & Safe Entry Trade Reports - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Using AI based signals to follow IGC Pharma Inc.2025 Risk Factors & Growth-Oriented Investment Plans - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Long term hold vs stop loss in IGC Pharma Inc.Trade Analysis Report & Weekly Momentum Picks - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Is now a turning point for IGC Pharma Inc.Trade Entry Report & Fast Moving Trade Plans - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

How IGC Pharma Inc. stock performs during market volatilityJuly 2025 Drop Watch & Daily Stock Trend Reports - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Real time breakdown of IGC Pharma Inc. stock performanceEarnings Overview Report & Expert Approved Momentum Ideas - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Can machine learning forecast IGC Pharma Inc. recoveryWeekly Profit Summary & Risk Managed Investment Entry Signals - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Trend analysis for IGC Pharma Inc. this weekJuly 2025 Price Swings & Verified Entry Point Signals - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

What’s the recovery path for long term holders of IGC Pharma Inc.Trade Performance Summary & Fast Exit and Entry Strategy Plans - Newser

Aug 26, 2025
pulisher
Aug 25, 2025

Risk vs reward if holding onto IGC Pharma Inc.July 2025 Weekly Recap & Community Consensus Stock Picks - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Is IGC Pharma Inc. stock bottoming out2025 Sector Review & Low Risk High Reward Ideas - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

IGC Pharma Expands CALMA Phase 2 Trial with Site at Lynn Health Science Institute in Oklahoma City - ACCESS Newswire

Aug 25, 2025
pulisher
Aug 25, 2025

Major Alzheimer's Agitation Treatment Trial Expands: IGC Pharma Adds Oklahoma Research Site - Stock Titan

Aug 25, 2025
pulisher
Aug 25, 2025

Key metrics from IGC Pharma Inc.’s quarterly dataJuly 2025 Fed Impact & Low Drawdown Investment Ideas - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Is IGC Pharma Inc. likely to announce a buybackJuly 2025 Trade Ideas & Real-Time Market Sentiment Reports - sundaytimes.kr

Aug 25, 2025
pulisher
Aug 24, 2025

IGC Pharma Inc. Added to High Probability Setup ListWeekly Trend Recap & Free Long-Term Investment Growth Plans - newsyoung.net

Aug 24, 2025
pulisher
Aug 24, 2025

IGC Pharma Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingQuarterly Profit Summary & Smart Money Movement Alerts - Newser

Aug 24, 2025
pulisher
Aug 23, 2025

IGC Pharma Inc. stock retracement – recovery analysisJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - Newser

Aug 23, 2025
pulisher
Aug 23, 2025

Can IGC Pharma Inc. recover in the next quarterPortfolio Value Summary & Weekly Momentum Stock Picks - Newser

Aug 23, 2025
pulisher
Aug 22, 2025

What hedge funds are buying IGC Pharma Inc.2025 Trading Recap & AI Powered Buy/Sell Recommendations - sundaytimes.kr

Aug 22, 2025
pulisher
Aug 21, 2025

Can IGC Pharma Inc. outperform in the next rallyBond Market & Breakout Confirmation Trade Signals - kpenews.com

Aug 21, 2025
pulisher
Aug 20, 2025

IGC Pharma Reports Q1 EPS, Revenue Growth, and Advances Clinical Trials for Alzheimer's Treatment - AInvest

Aug 20, 2025
pulisher
Aug 20, 2025

How to build a dashboard for IGC Pharma Inc. stock2025 EndofYear Setup & High Conviction Trade Alerts - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Understanding IGC Pharma Inc.’s price movementEarnings Growth Report & Expert-Curated Trade Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

IGC Pharma Inc. Reaches Critical Trendline SupportJuly 2025 Closing Moves & Consistent Profit Focused Trading Strategies - kangso.co.kr

Aug 19, 2025
pulisher
Aug 19, 2025

Published on: 2025-08-19 15:10:24 - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

IGC Pharma : Notice & Access 2025 ASM - MarketScreener

Aug 19, 2025
pulisher
Aug 19, 2025

IGC Pharma : Letter to Stockholders FYE2025 Annual Report - MarketScreener

Aug 19, 2025
pulisher
Aug 19, 2025

Can a trend reversal in IGC Pharma Inc. lead to recoveryPortfolio Update Summary & Reliable Entry Point Trade Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

IGC Pharma Reports Q1 FY2026 Financial Results, Accelerates Phase 2 Alzheimer's Trial - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Clinical-Stage Biotech IGC Pharma Cuts Costs 28%, Accelerates Alzheimer's Trial Targeting 76% Patient Need - Stock Titan

Aug 19, 2025
pulisher
Aug 19, 2025

Igc Pharma’s Risky Venture: Navigating Financial Instability Amid Bitcoin Investment Plans - MSN

Aug 19, 2025
pulisher
Aug 18, 2025

Volume Profile Shows Strong Base for IGC Pharma Inc.Portfolio Risk Report & Accurate Trade Setup Notifications - kangso.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

Can IGC Pharma Inc. weather a recession2025 Risk Factors & AI Powered Market Trend Analysis - 더경남뉴스

Aug 18, 2025
pulisher
Aug 18, 2025

Evaluating IGC Pharma Inc. with trendline analysis2025 Investor Takeaways & AI Powered Market Entry Ideas - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Should you avoid IGC Pharma, Inc. stock right nowTrade Performance Summary & Technical Pattern Alert System - 더경남뉴스

Aug 17, 2025
pulisher
Aug 17, 2025

Sector ETF performance correlation with IGC Pharma Inc.2025 Market Outlook & Momentum Based Trading Ideas - Newser

Aug 17, 2025

IGC Pharma Inc Azioni (IGC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$24.68
price up icon 0.59%
$84.63
price up icon 0.77%
$24.29
price down icon 9.64%
$103.63
price down icon 0.75%
$133.41
price up icon 0.97%
biotechnology ONC
$299.82
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):